These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30632883)

  • 1. 'I saw it as a second chance': A qualitative exploration of experiences of treatment failure and regimen change among people living with HIV on second- and third-line antiretroviral therapy in Kenya, Malawi and Mozambique.
    Burns R; Borges J; Blasco P; Vandenbulcke A; Mukui I; Magalasi D; Molfino L; Manuel R; Schramm B; Wringe A
    Glob Public Health; 2019 Aug; 14(8):1112-1124. PubMed ID: 30632883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "I take my pills every day, but then it goes up, goes down. I don't know what's going on": Perceptions of HIV virological failure in a rural context in Mozambique. A qualitative research study.
    Pulido Tarquino IA; Venables E; de Amaral Fidelis JM; Giuliani R; Decroo T
    PLoS One; 2019; 14(6):e0218364. PubMed ID: 31206540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "We give them threatening advice…": expectations of adherence to antiretroviral therapy and their consequences among adolescents living with HIV in rural Malawi.
    Burns R; Magalasi D; Blasco P; Szumilin E; Pasquier E; Schramm B; Wringe A
    J Int AIDS Soc; 2020 Mar; 23(3):e25459. PubMed ID: 32124554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slipping through the cracks: a qualitative study to explore pathways of HIV care and treatment amongst hospitalised patients with advanced HIV in Kenya and the Democratic Republic of the Congo.
    Burns R; Venables E; Odhoch L; Kocholla L; Wanjala S; Mucinya G; Bossard C; Wringe A
    AIDS Care; 2022 Sep; 34(9):1179-1186. PubMed ID: 34445917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
    Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
    BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative exploration of perceived benefits of care and barriers influencing HIV care in trans Nzoia, Kenya.
    Naanyu V; Ruff J; Goodrich S; Spira T; Bateganya M; Toroitich-Ruto C; Otieno-Nyunya B; Siika AM; Wools-Kaloustian K
    BMC Health Serv Res; 2020 Apr; 20(1):355. PubMed ID: 32334601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Blood pressure can kill you tomorrow, but HIV gives you time': illness perceptions and treatment experiences among Malawian individuals living with HIV and hypertension.
    Hing M; Hoffman RM; Seleman J; Chibwana F; Kahn D; Moucheraud C
    Health Policy Plan; 2019 Nov; 34(Supplement_2):ii36-ii44. PubMed ID: 31723966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 9. 'Side effects' are 'central effects' that challenge retention in HIV treatment programmes in six sub-Saharan African countries: a multicountry qualitative study.
    Renju J; Moshabela M; McLean E; Ddaaki W; Skovdal M; Odongo F; Bukenya D; Wamoyi J; Bonnington O; Seeley J; Zaba B; Wringe A
    Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplifying switch to second-line antiretroviral therapy in sub Saharan Africa: predicted effect of using a single viral load to define efavirenz-based first-line failure.
    Shroufi A; Van Cutsem G; Cambiano V; Bansi-Matharu L; Duncan K; Murphy RA; Maman D; Phillips A
    AIDS; 2019 Aug; 33(10):1635-1644. PubMed ID: 31305331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livelihood experiences and adherence to HIV antiretroviral therapy among participants in a food assistance pilot in Bolivia: a qualitative study.
    Palar K; Martin A; Oropeza Camacho ML; Derose KP
    PLoS One; 2013; 8(4):e61935. PubMed ID: 23613976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapting an adherence support workers intervention: engaging traditional healers as adherence partners for persons enrolled in HIV care and treatment in rural Mozambique.
    Audet CM; Salato J; Vermund SH; Amico KR
    Implement Sci; 2017 Apr; 12(1):50. PubMed ID: 28407813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to and facilitators of adherence to antiretroviral therapy among people living with HIV in Lao PDR: a qualitative study.
    Portelli MS; Tenni B; Kounnavong S; Chanthivilay P
    Asia Pac J Public Health; 2015 Mar; 27(2):NP778-88. PubMed ID: 22535549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'I am treated well if I adhere to my HIV medication': putting patient-provider interactions in context through insights from qualitative research in five sub-Saharan African countries.
    Ondenge K; Renju J; Bonnington O; Moshabela M; Wamoyi J; Nyamukapa C; Seeley J; Wringe A; Skovdal M
    Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional needs of patients living and dying with heart failure in Kenya: a serial interview study.
    Kimani KN; Murray SA; Grant L
    BMC Palliat Care; 2018 Feb; 17(1):28. PubMed ID: 29454383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient experiences of ART adherence clubs in Khayelitsha and Gugulethu, Cape Town, South Africa: A qualitative study.
    Venables E; Towriss C; Rini Z; Nxiba X; Cassidy T; Tutu S; Grimsrud A; Myer L; Wilkinson L
    PLoS One; 2019; 14(6):e0218340. PubMed ID: 31220116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation and Operational Research: Correlates of Adherence and Treatment Failure Among Kenyan Patients on Long-term Highly Active Antiretroviral Therapy.
    Ochieng W; Kitawi RC; Nzomo TJ; Mwatelah RS; Kimulwo MJ; Ochieng DJ; Kinyua J; Lagat N; Onyango KO; Lwembe RM; Mwamburi M; Ogutu BR; Oloo FA; Aman R
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):e49-56. PubMed ID: 26009836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Only twice a year': a qualitative exploration of 6-month antiretroviral treatment refills in adherence clubs for people living with HIV in Khayelitsha, South Africa.
    Keene CM; Zokufa N; Venables EC; Wilkinson L; Hoffman R; Cassidy T; Snyman L; Grimsrud A; Voget J; von der Heyden E; Zide-Ndzungu S; Bhardwaj V; Isaakidis P
    BMJ Open; 2020 Jul; 10(7):e037545. PubMed ID: 32641338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adherence reinforcement for antiretroviral therapy: PLHIV's perceptions and experience in Burkina Faso].
    Berthé-Sanou L; Sanou M; Berthé A; Ouédraogo R; Sawadogo AB; Drabo J; Moh R; Tubiana R; Slama L; Desclaux A
    Sante Publique; 2019; 31(6):855-864. PubMed ID: 32550668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.